A detailed history of Acadian Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Acadian Asset Management LLC holds 149,660 shares of NVO stock, worth $13.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
149,660
Previous 349,954 57.23%
Holding current value
$13.1 Million
Previous $49.9 Million 64.34%
% of portfolio
0.06%
Previous 0.15%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $23.8 Million - $29.1 Million
-200,294 Reduced 57.23%
149,660 $17.8 Million
Q2 2024

Aug 06, 2024

SELL
$122.71 - $146.91 $110 Million - $131 Million
-894,174 Reduced 71.87%
349,954 $49.9 Million
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $118 Million - $157 Million
1,155,313 Added 1300.81%
1,244,128 $160 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $7.28 Million - $8.75 Million
82,963 Added 1417.69%
88,815 $9.18 Million
Q3 2023

Nov 13, 2023

SELL
$90.94 - $199.54 $258,451 - $567,092
-2,842 Reduced 32.69%
5,852 $531,000
Q2 2023

Aug 07, 2023

BUY
$155.98 - $172.65 $647,161 - $716,324
4,149 Added 91.29%
8,694 $1.41 Million
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $562,842 - $676,822
-4,253 Reduced 48.34%
4,545 $723,000
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $108,190 - $142,773
-1,055 Reduced 10.71%
8,798 $1.19 Million
Q1 2022

May 12, 2022

SELL
$93.1 - $112.54 $164,693 - $199,083
-1,769 Reduced 15.22%
9,853 $1.09 Million
Q4 2021

Feb 10, 2022

SELL
$95.88 - $117.08 $15,532 - $18,966
-162 Reduced 1.37%
11,622 $1.3 Million
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $994,805 - $1.26 Million
11,784 New
11,784 $1.13 Million
Q1 2021

May 11, 2021

SELL
$67.06 - $75.82 $1.18 Million - $1.33 Million
-17,559 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$63.89 - $73.8 $575 - $664
-9 Reduced 0.05%
17,559 $1.23 Million
Q2 2020

Aug 12, 2020

BUY
$58.54 - $67.94 $78,853 - $91,515
1,347 Added 8.3%
17,568 $1.15 Million
Q1 2020

May 11, 2020

BUY
$49.46 - $64.78 $802,290 - $1.05 Million
16,221 New
16,221 $977,000
Q4 2019

Feb 06, 2020

SELL
$49.86 - $58.26 $46,519 - $54,356
-933 Closed
0 $0
Q3 2019

Nov 07, 2019

BUY
$47.54 - $53.43 $44,354 - $49,850
933 New
933 $48,000
Q4 2017

Jan 18, 2018

SELL
$47.53 - $53.73 $60,505 - $68,398
-1,273 Closed
0 $0
Q3 2017

Oct 13, 2017

BUY
$41.15 - $49.22 $52,383 - $62,657
1,273
1,273 $61,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.